Stanford spin-out NuMedii closes $3.5m series A for big data pharma platform.

NuMedii, a big data spin-out of Stanford University, has received $3.5m in a series A round to develop its pharma platform.

The round was led by venture firms Claremont Creek Ventures and Lightspeed Venture Partners with participation by Life Science Angels and other angels.

NuMedii’s platform looks to pair existing drugs with new disease applications through the use of big data instead of wet labs. The company, launched in 2008, has already signed its first product-focused deal with cystic fibrosis…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.

Not sure if you have a subscription?